Literature DB >> 6801109

Fragilitas ossium: a new autosomal recessive mutation in the mouse.

J L Guenet, R Stanescu, P Maroteaux, V Stanescu.   

Abstract

Fragilitas ossium, fro, is an often lethal recessive mutation that was discovered in a randombred stock of mice after treatment with the chemical mutagen tris(1-aziridinyl) phosphine-sulphine. The fro/fro mice have osteoporosis-bending and fracture of the long bones-that is associated with apparently normal cartilage growth. The roentgenological and pathological features are similar to those of the severe, often lethal recessive form of human osteogenesis imperfecta.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6801109     DOI: 10.1093/oxfordjournals.jhered.a109554

Source DB:  PubMed          Journal:  J Hered        ISSN: 0022-1503            Impact factor:   2.645


  18 in total

1.  Sphingomyelin degradation is a key factor in dentin and bone mineralization: lessons from the fro/fro mouse. The chemistry and histochemistry of dentin lipids.

Authors:  M Goldberg; S Opsahl; I Aubin; D Septier; C Chaussain-Miller; A Boskey; J-L Guenet
Journal:  J Dent Res       Date:  2008-01       Impact factor: 6.116

2.  Smpd3 Expression in both Chondrocytes and Osteoblasts Is Required for Normal Endochondral Bone Development.

Authors:  Jingjing Li; Garthiga Manickam; Seemun Ray; Chun-do Oh; Hideyo Yasuda; Pierre Moffatt; Monzur Murshed
Journal:  Mol Cell Biol       Date:  2016-08-12       Impact factor: 4.272

3.  Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.

Authors:  Michael B Dinkins; John Enasko; Caterina Hernandez; Guanghu Wang; Jina Kong; Inas Helwa; Yutao Liu; Alvin V Terry; Erhard Bieberich
Journal:  J Neurosci       Date:  2016-08-17       Impact factor: 6.167

Review 4.  Malformation syndromes: a review of mouse/human homology.

Authors:  R M Winter
Journal:  J Med Genet       Date:  1988-07       Impact factor: 6.318

Review 5.  Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.

Authors:  Michael B Dinkins; Guanghu Wang; Erhard Bieberich
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis.

Authors:  M Matsushita; T Tsuboyama; R Kasai; H Okumura; T Yamamuro; K Higuchi; K Higuchi; A Kohno; T Yonezu; A Utani
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

7.  Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.

Authors:  Jochen Schulze; Sebastian Seitz; Hiroaki Saito; Michael Schneebauer; Robert P Marshall; Anke Baranowsky; Bjoern Busse; Arndt F Schilling; Felix W Friedrich; Joachim Albers; Alexander S Spiro; Jozef Zustin; Thomas Streichert; Kristina Ellwanger; Christof Niehrs; Michael Amling; Roland Baron; Thorsten Schinke
Journal:  PLoS One       Date:  2010-04-27       Impact factor: 3.240

8.  Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.

Authors:  S D Chipman; H O Sweet; D J McBride; M T Davisson; S C Marks; A R Shuldiner; R J Wenstrup; D W Rowe; J R Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Comparison of bone tissue properties in mouse models with collagenous and non-collagenous genetic mutations using FTIRI.

Authors:  Rhima M Coleman; Laura Aguilera; Layla Quinones; Lyudamila Lukashova; Christophe Poirier; Adele Boskey
Journal:  Bone       Date:  2012-08-15       Impact factor: 4.398

10.  Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression.

Authors:  Wilhelm Stoffel; Britta Jenke; Barbara Holz; Erika Binczek; Robert Heinz Günter; Jutta Knifka; Jürgen Koebke; Anja Niehoff
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.